We are live on ! Find out more
CPHR

Cipher Pharmaceuticals Inc.
CPHR

Delisted

CPHR was delisted on the 8th of December, 2016.

31 hedge funds and large institutions have $55.7M invested in Cipher Pharmaceuticals Inc. in 2015 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 3

86% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 7

19% more funds holding

Funds holding: 2631 (+5)

7% more capital invested

Capital invested by funds: $51.8M → $55.7M (+$3.85M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
31
Holders Change
+5
Holders Change %
+19.23%
% of All Funds
0.83%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
8
Increased
13
Reduced
7
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
MBI
1
Montrusco Bolton Investments
Quebec, Canada
$12.7M +$17.6M +1,398,292 New
Acadian Asset Management
2
Acadian Asset Management
Massachusetts
$9.45M +$61.5K +4,900 +0.5%
OSAM
3
O'Shaughnessy Asset Management
Connecticut
$8.08M +$11.2M +893,421 New
TAM
4
Taylor Asset Management
Ontario, Canada
$5.19M +$730K +58,100 +11%
RA
5
Raffles Associates
New York
$4.06M -$1.16M -92,500 -17%
BIT
6
BlackRock Institutional Trust
California
$3.99M +$2.32M +184,505 +72%
IIM
7
Intact Investment Management
Quebec, Canada
$3.35M -$968K -77,100 -21%
Morgan Stanley
8
Morgan Stanley
New York
$1.47M +$574K +45,694 +39%
Canada Pension Plan Investment Board
9
Canada Pension Plan Investment Board
Ontario, Canada
$1.45M
Two Sigma Investments
10
Two Sigma Investments
New York
$980K -$56.5K -4,500 -4%
NEI
11
Northwest & Ethical Investments
Ontario, Canada
$938K -$16.8K -1,340 -1%
BlackRock
12
BlackRock
New York
$831K +$679K +54,054 +144%
SIM
13
Spark Investment Management
New York
$569K +$327K +26,000 +70%
QI
14
QS Investors
New York
$513K +$561K +44,700 New
ACM
15
Ativo Capital Management
Illinois
$422K -$88K -7,006 -13%
Renaissance Technologies
16
Renaissance Technologies
New York
$385K +$202K +16,100 +61%
Deutsche Bank
17
Deutsche Bank
Germany
$350K +$487K +38,800 New
GPGA
18
Grandeur Peak Global Advisors
Utah
$223K +$46.5K +3,700 +18%
AII
19
AGF Investments Inc
Ontario, Canada
$173K +$240K +19,100 New
BG
20
BlackRock Group
United Kingdom
$148K +$81K +6,452 +65%
Two Sigma Advisers
21
Two Sigma Advisers
New York
$127K -$42.7K -3,400 -20%
RFC
22
Russell Frank Company
Washington
$92K
Royal Bank of Canada
23
Royal Bank of Canada
Ontario, Canada
$59K +$27.6K +2,197 +51%
Bank of Montreal
24
Bank of Montreal
Ontario, Canada
$43K +$59.9K +4,769 New
Bank of America
25
Bank of America
North Carolina
$37K +$49K +3,900 +1,950%

CPHR Hedge Fund Activity: Q1 2015 in Review

31 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Cipher Pharmaceuticals Inc. (CPHR) for Q1 2015, worth a combined $55.7M — up 7.4% from $51.8M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new CPHR positions and 3 closed out — a net gain of 5 holders — while 13 added to existing stakes and 7 trimmed.

The largest buyer was Montrusco Bolton Investments, opening a new position worth an estimated $17.6M. The largest seller was Raffles Associates, cutting an estimated $1.16M.

  • 31 institutional investors held Cipher Pharmaceuticals Inc. (CPHR) as of Q1 2015, up from 26 in Q4 2014.
  • Funds reported $55.7M of Cipher Pharmaceuticals Inc. stock for Q1 2015, up 7.4% quarter-over-quarter.
  • 8 funds opened new Cipher Pharmaceuticals Inc. positions in Q1 2015 and 3 closed out, a net change of +5 holders.
  • The largest Cipher Pharmaceuticals Inc. buyer in Q1 2015 was Montrusco Bolton Investments, an estimated $17.6M added.
  • The largest Cipher Pharmaceuticals Inc. seller in Q1 2015 was Raffles Associates, an estimated $1.16M sold.

Based on aggregated 13F filings for Q1 2015.